Anti-Human NODAL Antibody (SAA1711)

Catalog No.

RHJ42601

Species reactivity

Human

Host species

Mouse

Isotype

IgG2a, kappa

Clonality

Monoclonal

Target

NODAL, Nodal homolog

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q96S42

Applications

ELISA

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

SAA1711

High-Sensitivity Flow Cytometric Detection of a Small Circulating Population of Nodal T-Follicular Helper Cell Lymphoma Angioimmunoblastic Type Cells., PMID:40503539

Case report: a R0 resection successfully induced by T-DXd plus PD-1 inhibitor regimen in a primary unresectable stage IIIB NSCLC with ERBB2-mutation., PMID:40494858

Application of serum anti-ENO1 and anti-SSNA1 antibody biomarkers in predicting the prognosis of gastric cancer., PMID:40469915

Co-expression of Stem Cell Markers CD133 and CD44 as Predictors of Metastatic Potential of Colorectal Carcinoma., PMID:40452184

Risk and prognosis of second primary malignancies in patients with follicular lymphoma in the era of rituximab: A population study based on the SEER database., PMID:40435210

Proprioceptive endings at muscle spindles as a possible target of autoantibodies., PMID:40424942

Biological and Clinical Relevance of Genetic Alterations in Peripheral T-cell Lymphomas., PMID:40416001

Synthetic organic materials for targeting immunotherapies to lymph nodes., PMID:40405914

Chronic Inflammatory Demyelinating Polyneuropathy: How Pathophysiology Can Guide Treatment., PMID:40391517

Rare Bloodstream Infection of Rhodococcus rhodochrous as the Prodromal Signal for Malignancy., PMID:40271228

Deficiency of MTAP Is Frequent and Mostly Homogeneous in Pancreatic Ductal Adenocarcinomas., PMID:40227771

Adjuvant Anti-PD-1 Monotherapy Versus Observation for Stage III Acral Melanoma of the Sole: A Multicenter Retrospective Study in Japanese Patients., PMID:40184568

[Update on marginal zone lymphoma classification, diagnosis and treatment in 2024]., PMID:40157832

Detection and agreement of blood- and lymph vessel invasion assessed by immunohistochemistry in matched TURBT and radical cystectomy specimens., PMID:40138884

Complete response of unilateral primary lacrimal sac diffuse large B-cell lymphoma treated without radiotherapy in an adult: A rare case report and review of the literature., PMID:40112523

Background Tissue with Native Target Expression Can Determine Presence of Nodal Metastasis in Head and Neck Squamous Cell Carcinoma Patients Infused with Targeted Fluorescent Tracers., PMID:40100567

Neoadjuvant treatment with immune checkpoint inhibitors in patients with melanoma: A real-life retrospective study., PMID:40091460

New treatment options for generalized HER2-positive breast cancer in higher-line systemic palliative therapy., PMID:40088439

SOHO State of the Art Updates and Next Questions: Treatment Options for Marginal Zone Lymphoma., PMID:40055115

Estrogen receptor expression in human tumors: A tissue microarray study evaluating more than 18,000 tumors from 149 different entities., PMID:40054585

Super-resolution of nodal and paranodal disruption in anti-pan-neurofascin-associated autoimmune nodopathy., PMID:40051618

Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized Clinical Trial., PMID:40048190

Predictors of Pathologic Complete Response with Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer., PMID:40025324

Inter-Laboratory Validation of Nodal/Paranodal Antibody Testing., PMID:39887819

Blocking the CD39/CD73 pathway synergizes with anti-CD20 bispecific antibody in nodal B-cell lymphoma., PMID:39884778

Detection of H-Pylori in the Explanted Liver Tissue and the Enlarged Perihepatic Lymph Nodes of Cirrhotic Patients with Decompensated End-Stage Liver Disease Recruited for Liver Transplantation., PMID:39874000

Clinicopathological study and molecular subtyping of muscle-invasive bladder cancer (MIBC) using dual immunohistochemical (IHC) markers., PMID:39856762

Evaluating CK20 and MCPyV Antibody Clones in Diagnosing Merkel Cell Carcinoma., PMID:39841326

Cripto-1 acts as a molecular bridge linking nodal to ALK4 via distinct structural domains., PMID:39840816

Breast Cancer Specificities of Patients With Anti-Ri Paraneoplastic Neurologic Syndromes., PMID:39823556

Tremelimumab plus Durvalumab prior to Chemoradiotherapy in Unresectable, Locally Advanced Non-Small Cell Lung Cancer: The Induction Trial., PMID:39821070

Outcome of extra-nodal follicular lymphoma affected by choice of induction chemoimmunotherapy and maintenance rituximab - real-world retrospective study., PMID:39731562

Metabolic Complete Response of Metastatic Oncogene-Negative, PDL1-Negative Non-Small Cell Lung Cancer After Chemo-Immunotherapy and Radiotherapy: A Case Report., PMID:39727721

Favorable long-term outcomes of autoimmune nodopathy with mycophenolate mofetil., PMID:39726762

[Diseases Separated from Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Anti-Myelin-Associated Glycoprotein Neuropathy and Autoimmune Nodopathy]., PMID:39725755

Efficacy of Combined Encorafenib and Binimetinib Treatment for Erdheim-Chester Disease Harboring Concurrent BRAFV600E and KRASG12R Mutations: A Case Report., PMID:39724464

Combined systemic treatments in two patients with ductal salivary carcinoma., PMID:39666421

Prevalence and clinical significance of Claudin-3 expression in cancer: a tissue microarray study on 14,966 tumor samples., PMID:39658782

BV and beyond: how to incorporate novel agents into PTCL management., PMID:39644004

Adjuvant Trastuzumab Plus Pertuzumab Versus Trastuzumab Alone in Patients Achieving Pathologic Complete Response After Chemotherapy With Trastuzumab and Pertuzumab: A Retrospective Cohort Study., PMID:39617646

Primary lung tumour stereotactic body radiotherapy followed by concurrent mediastinal chemoradiotherapy and adjuvant immunotherapy for locally advanced non-small-cell lung cancer: a multicentre, single-arm, phase 2 trial., PMID:39615497

De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial., PMID:39612919

PI3K/AKT Immunoexpression Influences the Prognostic Factors of Patients Diagnosed with Oropharyngeal Squamous Cell Carcinoma., PMID:39611903

Potential of epithelial membrane protein 3 as a novel therapeutic target for human breast cancer., PMID:39611484

CK5/6 Expression in Molecular Subtypes of Invasive Ductal Carcinoma., PMID:39610583

Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trial., PMID:39586309

Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trial., PMID:39551064

Primary Thyroid Lymphoma: A Rare Diagnosis Treated With Polatuzumab Vedotin., PMID:39548855

Reduced p63 expression is linked to unfavourable prognosis in muscle-invasive urothelial carcinoma of the bladder., PMID:39539567

Prevalence and Significance of AGR2 Expression in Human Cancer., PMID:39533806

Document Download

Anti-Human NODAL Antibody (SAA1711).pdf